Real world – Car-T Central

Summary of real-world evidence: ASH 2022

Real-world evidence continues to be made available of CAR-T in the clinic. A series of studies into real-world effectiveness of CAR-T therapies were presented at ASH 2022. Here we present two notable abstracts:

Race and ethnicity in CAR-T therapies: Efficacy and Access

Minority ethnic and racial groups are underrepresented in clinical trials leading to a reliance on real-world data for understanding the effects in these groups. Here we report on real-world data presented at ASCO 2022 on this topic.